Advertisement
Screener

EyePoint, Inc. (EYPT) License and Services Revenue (Deprecated 2018-01-31)

2.5 / 5 stars · 47/94 Roast Me

EyePoint, Inc. License and Services Revenue (Deprecated 2018-01-31)

EyePoint, Inc. (EYPT) reported License and Services Revenue (Deprecated 2018-01-31) of $524.00 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-10.

Discontinued › Income Statement › Other Income

us-gaap:LicenseAndServicesRevenue · last filed 2018-05-10

  • EyePoint, Inc. license and services revenue (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $524.00K, a 40.86% increase year-over-year.
  • EyePoint, Inc. license and services revenue (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $461.00K, a 91.92% decline year-over-year.
  • EyePoint, Inc. license and services revenue (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $140.00K, a 311.76% increase year-over-year.
  • EyePoint, Inc. license and services revenue (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $461.00K, a 1673.08% increase year-over-year.
  • EyePoint, Inc. license and services revenue (deprecated 2018-01-31) for fiscal 2017 was $6.57M, a 1550.50% increase from fiscal 2016.
  • EyePoint, Inc. license and services revenue (deprecated 2018-01-31) for fiscal 2016 was $398.00K, a 98.43% decline from fiscal 2015.
  • EyePoint, Inc. license and services revenue (deprecated 2018-01-31) for fiscal 2015 was $25.41M, a 1079.16% increase from fiscal 2014.
  • EyePoint, Inc. license and services revenue (deprecated 2018-01-31) for fiscal 2014 was $2.15M, a 176.28% increase from fiscal 2013.
Period endLicense and Services Revenue (Deprecated 2018-01-31) 3 monthLicense and Services Revenue (Deprecated 2018-01-31) 3 month as first filedLicense and Services Revenue (Deprecated 2018-01-31) 6 monthLicense and Services Revenue (Deprecated 2018-01-31) 9 monthLicense and Services Revenue (Deprecated 2018-01-31) 12 month
2018-03-31$524.00K
10-Q · filed 2018-05-10
$985.00K
derived: sum of 2 quarters · filed 2018-05-10
$1.13M
10-Q · filed 2018-05-10
$1.59M
derived: sum of 4 quarters · filed 2018-05-10
2017-12-31$461.00K
10-Q · filed 2018-02-08
$601.00K
10-Q · filed 2018-02-08
$1.06M
derived: sum of 3 quarters · filed 2018-02-08
$1.43M
derived: sum of 4 quarters · filed 2018-05-10
2017-09-30$140.00K
10-Q · filed 2017-11-08
$601.00K
derived: sum of 2 quarters · filed 2017-11-08
$973.00K
derived: sum of 3 quarters · filed 2018-05-10
$6.67M
derived: sum of 4 quarters · filed 2018-05-10
2017-06-30$461.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-13
$833.00K
derived: sum of 2 quarters · filed 2018-05-10
$6.54M
derived: sum of 3 quarters · filed 2018-05-10
$6.57M
10-K · filed 2017-09-13
2017-03-31$372.00K
10-Q · filed 2018-05-10
$6.07M
derived: sum of 2 quarters · filed 2018-05-10
$6.11M
10-Q · filed 2018-05-10
$6.13M
derived: sum of 4 quarters · filed 2018-05-10
2016-12-31$5.70M
10-Q · filed 2018-02-08
$5.74M
10-Q · filed 2018-02-08
$5.76M
derived: sum of 3 quarters · filed 2018-02-08
$5.81M
derived: sum of 4 quarters · filed 2018-02-08
2016-09-30$34.00K
10-Q · filed 2017-11-08
$60.00K
derived: sum of 2 quarters · filed 2017-11-08
$110.00K
derived: sum of 3 quarters · filed 2017-11-08
$252.00K
derived: sum of 4 quarters · filed 2017-11-08
2016-06-30$26.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-13
$76.00K
derived: sum of 2 quarters · filed 2017-09-13
$218.00K
derived: sum of 3 quarters · filed 2017-09-13
$398.00K
10-K · filed 2017-09-13
2016-03-31$50.00K
10-Q · filed 2017-05-08
$192.00K
derived: sum of 2 quarters · filed 2017-05-08
$372.00K
10-Q · filed 2017-05-08
$428.00K
derived: sum of 4 quarters · filed 2017-09-13
2015-12-31$142.00K
10-Q · filed 2017-02-09
$322.00K
10-Q · filed 2017-02-09
$378.00K
derived: sum of 3 quarters · filed 2017-09-13
$488.00K
derived: sum of 4 quarters · filed 2017-09-13
2015-09-30$180.00K
10-Q · filed 2016-11-08
$236.00K
derived: sum of 2 quarters · filed 2017-09-13
$346.00K
derived: sum of 3 quarters · filed 2017-09-13
$510.00K
derived: sum of 4 quarters · filed 2017-09-13
2015-06-30$56.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-13
$166.00K
derived: sum of 2 quarters · filed 2017-09-13
$330.00K
derived: sum of 3 quarters · filed 2017-09-13
$25.41M
10-K · filed 2017-09-13
2015-03-31$110.00K
10-Q · filed 2016-05-06
$274.00K
derived: sum of 2 quarters · filed 2016-05-06
$25.36M
10-Q · filed 2016-05-06
$25.36M
derived: sum of 4 quarters · filed 2016-09-13
2014-12-31$164.00K
10-Q · filed 2016-02-09
$25.25M
10-Q · filed 2016-02-09
$25.25M
derived: sum of 3 quarters · filed 2016-09-13
$26.93M
derived: sum of 4 quarters · filed 2016-09-13
2014-09-30$25.08M
10-Q · filed 2015-11-06
$25.09M
derived: sum of 2 quarters · filed 2016-09-13
$26.76M
derived: sum of 3 quarters · filed 2016-09-13
$27.06M
derived: sum of 4 quarters · filed 2016-09-13
2014-06-30$6.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-13
$1.68M
derived: sum of 2 quarters · filed 2016-09-13
$1.98M
derived: sum of 3 quarters · filed 2016-09-13
$2.15M
10-K · filed 2016-09-13
2014-03-31$1.68M
10-Q · filed 2015-05-08
$1.98M
derived: sum of 2 quarters · filed 2015-05-08
$2.15M
10-Q · filed 2015-05-08
$2.33M
derived: sum of 4 quarters · filed 2015-09-10
2013-12-31$300.00K
10-Q · filed 2015-02-06
$473.00K
10-Q · filed 2015-02-06
$650.00K
derived: sum of 3 quarters · filed 2015-09-10
$889.00K
derived: sum of 4 quarters · filed 2015-09-10
2013-09-30$173.00K
10-Q · filed 2014-11-07
$350.00K
derived: sum of 2 quarters · filed 2015-09-10
$589.00K
derived: sum of 3 quarters · filed 2015-09-10
$784.00K
derived: sum of 4 quarters · filed 2015-09-10
2013-06-30$177.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-10
$416.00K
derived: sum of 2 quarters · filed 2015-09-10
$611.00K
derived: sum of 3 quarters · filed 2015-09-10
$780.00K
10-K · filed 2015-09-10
2013-03-31$239.00K
10-Q · filed 2014-05-14
$434.00K
derived: sum of 2 quarters · filed 2014-05-14
$603.00K
10-Q · filed 2014-05-14
$860.00K
derived: sum of 4 quarters · filed 2014-09-11
2012-12-31$195.00K
10-Q · filed 2014-02-12
$364.00K
10-Q · filed 2014-02-12
$621.00K
derived: sum of 3 quarters · filed 2014-09-11
$779.00K
derived: sum of 4 quarters · filed 2014-09-11
2012-09-30$169.00K
10-Q · filed 2013-11-13
$426.00K
derived: sum of 2 quarters · filed 2014-09-11
$584.00K
derived: sum of 3 quarters · filed 2014-09-11
$788.00K
derived: sum of 4 quarters · filed 2014-09-11
2012-06-30$257.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-11
$415.00K
derived: sum of 2 quarters · filed 2014-09-11
$619.00K
derived: sum of 3 quarters · filed 2014-09-11
$2.08M
10-K · filed 2014-09-11
2012-03-31$158.00K
10-Q · filed 2013-05-14
$362.00K
derived: sum of 2 quarters · filed 2013-05-14
$1.82M
10-Q · filed 2013-05-14
$4.76M
derived: sum of 4 quarters · filed 2013-09-27
2011-12-31$204.00K
10-Q · filed 2013-02-08
$1.67M
10-Q · filed 2013-02-08
$4.60M
derived: sum of 3 quarters · filed 2013-09-27
$4.66M
derived: sum of 4 quarters · filed 2013-09-27
2011-09-30$1.10M
10-K · filed 2013-09-27
$1.46M
10-Q/A · filed 2011-11-09
$4.40M
derived: sum of 2 quarters · filed 2013-09-27
$4.46M
derived: sum of 3 quarters · filed 2013-09-27
$4.54M
derived: sum of 4 quarters · filed 2013-09-27
2011-06-30$3.30M
10-K · filed 2012-09-27
$3.36M
derived: sum of 2 quarters · filed 2012-09-27
$3.44M
derived: sum of 3 quarters · filed 2012-09-27
$3.61M
10-K · filed 2013-09-27
2011-03-31$56.00K
10-Q · filed 2012-05-10
$144.00K
derived: sum of 2 quarters · filed 2012-05-10
$218.00K
10-Q · filed 2012-05-10
2010-12-31$88.00K
10-Q · filed 2012-02-09
$162.00K
10-Q · filed 2012-02-09
2010-09-30$74.00K
10-Q/A · filed 2011-11-09
2010-06-30$22.57M
10-K · filed 2012-09-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
908 Devices Inc. (MASS)United States$0.476B-9.53
Quanterix Corp (QTRX)United States$0.150B-1.65
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34
Precipio, Inc. (PRPO)United States$0.043B-36.70
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
ASTROTECH Corp (ASTC)United States$0.013B
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15